Saltar al contenido
Merck
Todas las fotos(1)

Documentos

14-792-M

Sigma-Aldrich

PI 3-Kinase (p110α(H1047R)/p85α), 10 µg

Complex of N-terminal 6His-tagged recombinant human p110α full length, containing the mutation H1047R & untagged, recombinant, human p85α full length.

Sinónimos:

Active PI 3-Kinase Protein, PI 3-Kinase p110α/p85α

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Código UNSPSC:
12352200
eCl@ss:
32160405
NACRES:
NA.32

origen biológico

human

Nivel de calidad

recombinante

expressed in baculovirus infected Sf21 cells

Línea del producto

Upstate®

formulario

liquid

actividad específica

(For Specific Activity data, refer to the Certificate of Analysis for individual lots of this enzyme.)

mol peso

Mw 125 kDa (p110α(H1047R))
Mw 84 kDa (p85α)

purificado por

(Ni2+/NTA-agarose)

reactividad de especies

human

fabricante / nombre comercial

Upstate®

color

colorless

solubilidad

water: soluble

nº de acceso

U79143

aplicaciones

life science and biopharma

Información sobre el gen

human ... PIK3CA(5290)

Descripción general

Research area: Cell Signaling

Complex of N-terminal 6His-tagged recombinant human p110α full length, containing the mutation H1047R, and untagged, recombinant, human p85α full length. The H1047R substitution is a somatic mutation in p110α that has been associated with tumours of the colon, stomach, breast, and brain. PI3Ks are categorized into three classes, namely class I, II, and III, based on their structural characteristics, substrate specificities, and the nature of lipid end-products. Class IA PI3Ks are composed of heterodimers that include a p110 catalytic subunit and a p85 regulatory subunit. In mammals, PIK3CA, PIK3CB, and PIK3CD, encode the p110 catalytic isoforms: p110α, p110β, and p110δ, respectively.

Acciones bioquímicas o fisiológicas

PI3 kinases play a critical role in various cellular processes such as cell survival, proliferation, differentiation, apoptosis, DNA repair, angiogenesis, cellular metabolism, and motility. PI3Ks can activate the serine/threonine kinase AKT and other downstream effector pathways by transmitting signals from growth factors and cytokines into intracellular messages. Genetic mutation in p110α is observed in breast, pancreatic, colon, liver, and lung cancers.Combined in vitro and in vivo studies have shown that this mutation confers higher lipid kinase activity than wild type, and can induce oncogenic transformation.

Envase

Also available in 10 μg size and in bulk
Also available in 250μg size --call for pricing and availability and reference catalog number 14-792M when ordering the 250μg size.

Descripción de destino

PI3Kα/p85α

Forma física

50 mM Tris/HCl pH8.0, 300 mM NaCl, 0.1 mM EGTA, 0.03% Brij-35, 270 mM sucrose, 0.2 mM PMSF, 1 mM benzamidine, 0.1% 2-mercaptoethanol. Frozen solution.

Otras notas

For Specific Activity data, refer to the Certificate of Analysis for individual lots of this enzyme.

Información legal

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Cláusula de descargo de responsabilidad

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Pictogramas

Exclamation mark

Palabra de señalización

Warning

Frases de peligro

Clasificaciones de peligro

Skin Sens. 1

Código de clase de almacenamiento

10 - Combustible liquids

Clase de riesgo para el agua (WGK)

WGK 1

Punto de inflamabilidad (°C)

Not applicable


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akinleye A, et al.
Journal of Hematology & Oncology, 6 (2013)
Targeting the phosphoinositide 3-kinase (PI3K) pathway in cancer
Liu P, et al.
Nature Reviews Drug Discovery, 8(8), 627?644-627?644 (2009)

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico